HR 3546
109th Congress
House
Health
Business records
Commerce
Drug industry
Drugs
Government Operations and Politics
Government publicity
Medicaid
Prescription pricing
Rebates
Social Welfare
Prescription Drug Pricing and Medicaid Fraud Prevention Act of 2005
Introduced: July 28, 2005
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 5, 2005
Referred to the Subcommittee on Health.
Jul 28, 2005
Referred to the House Committee on Energy and Commerce.
Jul 28, 2005
Introduced in House
Plain-English summary
Prescription Drug Pricing and Medicaid Fraud Prevention Act of 2005 - Amends title XIX (Medicaid) of the Social Security Act to require the Secretary of Health and Human Services to disclose publicly the average manufacturer prices (AMP) and best prices for prescription drugs.
Requires each drug manufacturer with a rebate agreement in effect to report to the Secretary detailed information (specified by the Secretary) on how the AMP is computed, including assumptions used.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2